Innovation Pharmaceuticals (IPIX) Financial Statements

134 Followers

Innovation Pharmaceuticals Financial Overview

Innovation Pharmaceuticals's market cap is currently $161.18K. The company's EPS TTM is $-0.0024; its P/E ratio is -0.05; Innovation Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Income Statement
Total Revenue	$ 0.00	$ 18.00K	$ 0.00	$ 423.00K	$ 0.00
Gross Profit	$ -373.00K	$ 18.00K	$ -378.00K	$ 423.00K	$ -371.00K
Operating Income	$ -3.11M	$ -6.92M	$ -9.02M	$ -4.63M	$ -6.45M
EBITDA	$ -2.74M	$ -6.54M	$ -8.64M	$ -6.01M	$ -6.11M
Net Income	$ -3.17M	$ -7.04M	$ -13.87M	$ -6.65M	$ -9.07M
Balance Sheet
Cash & Short-Term Investments	$ 1.52M	$ 3.81M	$ 10.19M	$ 6.02M	$ 579.00K
Total Assets	$ 7.52M	$ 10.38M	$ 14.30M	$ 9.25M	$ 4.05M
Total Debt	$ 725.00K	$ 1.29M	$ 1.87M	$ 2.46M	$ 1.92M
Net Debt	$ -1.25M	$ -2.52M	$ -8.32M	$ -3.56M	$ 1.34M
Total Liabilities	$ 5.48M	$ 5.65M	$ 6.79M	$ 7.79M	$ 8.18M
Stockholders' Equity	$ 2.04M	$ 4.73M	$ 7.51M	$ 1.46M	$ -4.13M
Cash Flow
Free Cash Flow	$ -2.17M	$ -6.36M	$ -9.57M	$ -4.25M	$ -6.42M
Operating Cash Flow	$ -2.11M	$ -6.28M	$ -9.49M	$ -4.16M	$ -6.33M
Investing Cash Flow	$ -60.00K	$ -4.08M	$ -72.00K	$ -91.00K	$ -46.00K
Financing Cash Flow	$ -123.00K	$ 3.97M	$ 13.74M	$ 9.69M	$ 4.53M

Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

Income Statement >

Innovation Pharmaceuticals Debt to Assets

Balance Sheet >

Innovation Pharmaceuticals Cash Flow

Cash Flow >

Innovation Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >